Michael Sweeting
AstraZeneca (United Kingdom)(GB)University of Leicester(GB)
Publications by Year
Research Areas
Aortic aneurysm repair treatments, Cardiac, Anesthesia and Surgical Outcomes, Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials, Aortic Disease and Treatment Approaches
Most-Cited Works
- → Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies(2006)2,465 cited
- → What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data(2004)1,679 cited
- → Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial(2016)1,049 cited
- → Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults(2018)805 cited
- → Association analyses based on false discovery rate implicate new loci for coronary artery disease(2017)782 cited
- → Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms(2012)528 cited